- transformed recombinant DNA into E. coli cultures- performed minipreps, midipreps, and maxipreps to purify recombinant DNA- confirmed identity of products through restriction digest screening- completed cloning through PCR amplification, restriction digest, gel extraction, and analysis of sequencing data

- established connections between ABM and institutional technology transfer offices- negotiated commercial licenses for immortalized, stable, and knockout mammalian cell lines- licensed three novel cell lines